Reuters logo
BRIEF-PSivida says 2nd phase 3 trial of Medidur met target enrollment
2016年10月4日 / 上午11点17分 / 1 年前

BRIEF-PSivida says 2nd phase 3 trial of Medidur met target enrollment

Oct 4 (Reuters) - PSivida Corp :

* PSivida corp says filing for EU registration remains on track for first calendar quarter of 2017

* Infectious posterior segment uveitis met its target enrollment of 150 patients

* PSivida Corp says results of both phase 3 trials will support us product registration, with NDA submission planned for second half of 2017

* Filing for EU registration remains on track for first calendar quarter of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below